iiinova — where your digital self keeps evolving

sandhyasuresh.bsky.social

@sandhyasuresh.bsky.social

296 followers 546 following 4 posts

sandhyasuresh.bsky.social @sandhyasuresh.bsky.social · 11/09/2025

Commentary on the continuing debate on Rtx dosing in MN byby Dr Joyita and Dr Ramachandran. It was a great learning experience to edit the article during the submission process under Dr Ramachandran's guidance. indianjnephrol.org/optimizing-r...

indianjnephrol.org

Optimizing Rituximab Dosing in Membranous Nephropathy: A Continuing Debate

000

sandhyasuresh.bsky.social @sandhyasuresh.bsky.social · 11/09/2025

Thanks to all my professors and colleagues for their guidance and support throughout

100

sandhyasuresh.bsky.social @sandhyasuresh.bsky.social · 11/09/2025

Super elated that our study - pilot RCT comparing low dose Ritux vs modified Ponticelli in MN - got published in IJN! indianjnephrol.org/low-dose-rit...

indianjnephrol.org

Low-Dose Rituximab vs. Modified Ponticelli Regimen in the Treatment of Primary Membranous Nephropathy – A Randomized Controlled Trial

100

Reposted by @sandhyasuresh.bsky.social

Arvind (Canchi) Conjeevaram @arvindcanchi.bsky.social · 11/09/2025

Low dose Rituximab (2 doses 500 mg given 15d apart) vs modified Ponticelli in PMN - pilot RCT suggests that low-dose RTX could achieve sufficient B-cell suppressn & short-term remission rates comparable to mPR with fewer adverse events @sandhyasuresh.bsky.social indianjnephrol.org/low-dose-rit...

251

sandhyasuresh.bsky.social @sandhyasuresh.bsky.social · 29/03/2025

Join in at 8PM today for the INFORM meeting of this month. I'll be presenting about our experience in SRMC with bedside ultrasound guided percutaneous insertion of PD catheters (without flouroscopy) us06web.zoom.us/j/4441727826...

010